Review of Drug Study protocols related to Dementia Trials in Canada
Drug protocols may be submitted to Trish Purcell, C5R Business Manager.
The Protocol Review and Selection Committee of C5R, will confidentially examine the research protocols, in order to determine C5R’s interest in participating.
C5R is then mandated to contact all Canadian site members of C5R in order to gauge interest and ability to carry out the study.
The C5R budget officer prepares a budget for studies on behalf of the Canadian sites, streamlining the negotiation process. C5R selects a scientific review team to examine the protocol and make any suggestions to the sponsor.
An administrative fee covers this entire procedure.
Pharmaceutical and Biotechnology companies may become corporate members of the C5R. These industry partners pay dues, receive copies of our communications, and have access to non-protected components of our web-site.
To inquire about collaboration with C5R, please fill out the form below, or visit our contact page
* indicates a required field